Confirmation Test

Product Description 

This add-on service provides access to laboratory-based testing designed to follow an initial at-home screening result. While screening devices offer preliminary information, this service connects users with a certified laboratory for more advanced analysis of a collected specimen. The process is intended for informational purposes only and does not replace clinical evaluation or medical advice. Results are reported in a clear, easy-to-understand format, allowing individuals to make more informed personal decisions. This service is available on-demand and is designed to support privacy, convenience, and responsible use of at-home testing solutions.  

Privacy & Personal Information Disclaimer

This service is designed with privacy in mind. We do not collect, store, or maintain personal health information or identifiable patient data. Each sample is assigned a unique MDID assessment number, which is used to track and report results in an anonymized manner.

No personally identifiable information is required to access or receive results through this service. The MDID assessment number serves as the only reference for the specimen and associated report.

By design, this process helps protect user confidentiality while providing access to laboratory-based testing. Users are responsible for maintaining their MDID assessment number, as it is the sole means of retrieving results.

This service is intended for informational purposes only and does not create a patient-provider relationship or constitute medical advice.

Drugs Tested

Samples submitted for confirmation testing will be analyzed by a certified laboratory for a standardized panel of seventeen (17) drug classes at established cutoff levels, regardless of the type or brand of preliminary screening device used. This service is designed to accept specimens originating from cups purchased through our company or from other manufacturers. The confirmation analysis includes the following drug categories: amphetamines (AMP 500), barbiturates (BAR 300), buprenorphine (BUP 10), benzodiazepines (BZO 300), cocaine (COC 150), MDMA (ecstasy 50), methamphetamine (MET 500), opiates (OPI 300), oxycodone (OXY 100), methadone (MTD 300), phencyclidine (PCP 25), marijuana (THC 50), tricyclic antidepressants (TCA 1000), EDDP (methadone metabolite 300), tramadol (TRA 100), 6-monoacetylmorphine (6-MAM 10), and fentanyl (FYL 1). Results are reported based on predefined laboratory cutoff thresholds and are intended for informational purposes only.

Why Someone Would Add Confirmation Testing

• Clarity when results are uncertain
  Helps users better understand unexpected or unclear screening results.
• Additional level of verification
  Provides a more advanced laboratory analysis following an initial screening test.
• Confidence for important decisions
  Useful when results may impact personal, family, or employment-related choices.
• Support for accountability and transparency
  Enables individuals to document results through an independent laboratory process.
• Discreet and convenient
  Can be accessed on an as-needed basis without requiring upfront commitment.
• Complements at-home screening
  Designed to follow a preliminary test, offering a next step when more information is desired.